Patent Assignment
Reel/Frame 061296/0185
Assignment of Assignor's Interest
Recorded: 2022-10-04
Pages: 5
Assignors
GEVA, MICHAL
Executed: 2022-04-20
LAUFER, RALPH
Executed: 2022-07-19
ORBACH, ARIC
Executed: 2022-07-11
Assignee
PRILENIA NEUROTHERAPEUTICS LTD.
HAMENOFIM 10, HERZLIYA, 4672561, ISRAEL
Covered Property
(1)
Treatment of Neurodegenerative Eye Disease Using Pridopidine
Application:
17/513,239 →
Publication:
US 2022/0062255
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Address
Nov 5, 2023
From: PRILENIA NEUROTHERAPEUTICS LTD.
To: PRILENIA NEUROTHERAPEUTICS LTD.
Reel/Frame 065460/0438 →
Assignment of Assignor's Interest
Nov 5, 2023
From: RUSS, HERMANN KURT
To: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Reel/Frame 065460/0673 →
Assignment of Assignor's Interest
Nov 5, 2023
From: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
To: PRILENIA THERAPEUTICS DEVELOPMENT LTD.
Reel/Frame 065460/0683 →